GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surgical Innovations Group PLC (LSE:SUN) » Definitions » 3-Year EPS without NRI Growth Rate

Surgical Innovations Group (LSE:SUN) 3-Year EPS without NRI Growth Rate : 37.00% (As of Dec. 2023)


View and export this data going back to 1988. Start your Free Trial

What is Surgical Innovations Group 3-Year EPS without NRI Growth Rate?

Surgical Innovations Group's EPS without NRI for the six months ended in Dec. 2023 was £0.00.

During the past 3 years, the average EPS without NRI Growth Rate was 37.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Surgical Innovations Group was 55.60% per year. The lowest was -80.00% per year. And the median was 26.00% per year.


Competitive Comparison of Surgical Innovations Group's 3-Year EPS without NRI Growth Rate

For the Medical Devices subindustry, Surgical Innovations Group's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surgical Innovations Group's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Surgical Innovations Group's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Surgical Innovations Group's 3-Year EPS without NRI Growth Rate falls into.



Surgical Innovations Group 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Surgical Innovations Group  (LSE:SUN) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Surgical Innovations Group 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Surgical Innovations Group's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Surgical Innovations Group (LSE:SUN) Business Description

Traded in Other Exchanges
N/A
Address
Clayton Wood House, 6 Clayton Wood Bank, Leeds, GBR, LS16 6QZ
Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery and precision engineering markets. The group sells branded products through independent healthcare distributors across the world and own-label products through original equipment manufacturer relationships. The SI Brand segment includes research, development, manufacture, and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture, and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. The distribution segment includes the distribution of specialist medical products.